Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin

Immunology and Cell Biology

Volumn 89, Issue 6, 2011, Pages 739-746

  Andrews, Daniel M ^a   Chow, Melvyn T ^a   Ma, Yuting ^b,c   Cotterell, Claire L ^a   Watt, Sally V ^a   Anthony, Desiree A ^a   Akira, Shizuo ^d   Iwakura, Yoichiro ^e,f   Trapani, Joseph A ^a   Zitvogel, Laurence ^b,c,g,h   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^g Center of Clinical Investigations in Biotherapies of Cancer CICBT 507   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

T cell; cross talk; cytokines; innate immunity; natural killer

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOTOXICOSIS; HOMEOSTASIS; INFLAMMATORY DISEASE; INNATE IMMUNITY; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN INTERACTION; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; HOMEOSTASIS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-18; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

MUS;

EID: 80051689338     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.168     Document Type: Article

References (48)

1. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005; 5: 112-124. (Pubitemid 40208901)
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765)
3. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
4. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667-672. (Pubitemid 34752476)
5. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386: 619-623. (Pubitemid 27175429)
6. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275: 206-209. (Pubitemid 27034760)
7. Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622. (Pubitemid 350236810)
8. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20-38.
9. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001; 166: 3672-3677. (Pubitemid 32224888)
10. Wang B, Feliciani C, Howell BG, Freed I, Cai Q, Watanabe H et al. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J Immunol 2002; 168: 3303-3308. (Pubitemid 34250392)
11. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-411.
12. Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun 2000; 68: 3502-3508. (Pubitemid 30340450)
13. Wu X, Hou W, Sun S, Bi E, Wang Y, Shi M et al. Novel function of IFN-gamma: negative regulation of dendritic cell migration and T cell priming. J Immunol 2006; 177: 934-943. (Pubitemid 44036594)
14. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994; 179: 1437-1444. (Pubitemid 24129561)
15. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 6: 1011-1019. (Pubitemid 41486186)
16. Chaix J, Tessmer MS, Hoebe K, Fuseri N, Ryffel B, Dalod M et al. Cutting edge: priming of NK cells by IL-18. J Immunol 2008; 181: 1627-1631.
17. Yu J, Wei M, Becknell B, Trotta R, Liu S, Boyd Z et al. Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006; 24: 575-590. (Pubitemid 43728149)
18. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31: 331-341.
19. Emoto M, Miyamoto M, Yoshizawa I, Emoto Y, Schaible UE, Kita E et al. Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice. J Immunol 2002; 169: 1426-1432. (Pubitemid 34809188)
20. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE et al. Adverse functions of IL-17A in experimental sepsis. Faseb J 2008; 22: 2198-2205. (Pubitemid 351948639)
21. Freitas A, Alves-Filho JC, Victoni T, Secher T, Lemos HP, Sonego F et al. IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 2009; 182: 7846-7854.
22. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132. (Pubitemid 41541790)
23. Watt SV, Andrews DM, Takeda K, Smyth MJ, Hayakawa Y. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J Immunol 2008; 181: 5323-5330.
24. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C et al. A role for IL-18 in neutrophil activation. J Immunol 2001; 167: 2879-2886. (Pubitemid 32768922)
25. Netea MG, Kullberg BJ, Verschueren I, Van Der Meer JW. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000; 30: 3057-3060.
26. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998; 101: 711-721. (Pubitemid 28084257)
27. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31: 321-330.
28. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ et al. CD27 is a thymic determinant of the balance between interferon-gamma-and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 2009; 10: 427-436.
29. Hodge DL, Martinez A, Julias JG, Taylor LS, Young HA. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol Cell Biol 2002; 22: 1742-1753. (Pubitemid 34174992)
30. Ye J, Ortaldo JR, Conlon K, Winkler-Pickett R, Young HA. Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol 1995; 58: 225-233.
31. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 2002; 108: 221-232. (Pubitemid 34161142)
32. Khabar KS, Young HA. Post-transcriptional control of the interferon system. Biochimie 2007; 89: 761-769. (Pubitemid 47001636)
33. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265. (Pubitemid 41057741)
34. Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock 2005; 24(Suppl 1): 7-11.
35. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M etal. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26: 1647-1651. (Pubitemid 26230016)
36. vande Wetering D, de Paus RA, van Dissel JT, van deVosse E. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. Int Immunol. 2009, 21: 145-153.
37. Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T et al. Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem Biophys Res Commun 1997; 234: 454-457. (Pubitemid 27243924)
38. Hayday AC. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000; 18: 975-1026. (Pubitemid 30365402)
39. Hayes SM, Love PE. A retrospective on the requirements for gammadelta T-cell development. Immunol Rev2007; 215: 8-14. (Pubitemid 46212226)
40. De Creus A, Van Beneden K, Stevenaert F, Debacker V, Plum J, Leclercq G. Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-1-deficient mice. J Immunol 2002; 168: 6486-6493. (Pubitemid 34620074)
41. Schluns KS, Nowak EC, Cabrera-Hernandez A, Puddington L, Lefrancois L, Aguila HL. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression. Proc Natl Acad Sci USA 2004; 101: 5616-5621. (Pubitemid 38481205)
42. Zhao H, Nguyen H, Kang J. Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes. Nat Immunol 2005; 6: 1263-1271. (Pubitemid 43045638)
43. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383-390. (Pubitemid 28188898)
44. Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008; 29: 628-636.
45. Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity. Cancer Lett 2008; 272: 285-295.
46. Smyth MJ, Ortaldo JR. Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J Immunol 1991; 146: 1380-1384.
47. Chan CJ, Andrews DM, McLaughlin NM, Yagita H, Gilfillan S, Colonna M etal. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases. J Immunol 2010; 184: 902-911.
48. Anthony DA, Andrews DM, Chow M, Watt SV, House C, Akira S et al. A role for granzyme M in TLR4-driven inflammation and endotoxicosis. J Immunol 2010; 185: 1794-1803.